Marie Brodbeck

Marie Brodbeck

Marie is a graduate of Duquesne University and has been a finance journalist for over a decade, when she began writing macroeconomic articles on a freelance basis. Since then, she has traveled the world and has been able to fund her lifestyle through a combination of savvy investments and frugal finances. She believes in taking risks when the market is fearful but always investing with a long-term view in mind.

Recent Articles

Virgin Galactic Stock Could Be Worth the Gamble, But We Won’t Know for Years

It's unclear whether commercial space travel will ever be profitable, but SPCE stock's going to try

Advanced Micro Devices Is in a Strong Spot

AMD stock may look expensive on the surface, but Advanced Micro Devices maker is actually fairly valued compared to semiconductor peers.

Peloton Stock Looks to Be Just Spinning Its Wheels at This Point

PTON stock still has a lot to prove before it will be a good investment-- the bike price cut is a step in the right direction, but the proof's in the pudding. If bikes don't fly off shelves this winter, the business could be in trouble.

Pfizer is a Clear Covid-19 Winner. Is That Enough?

Pfizer was strong before Covid-19 hit, but now it's on steroids. The valuation of PFE stock doesn't reflect the opportunity that lies ahead.

Lemonade Stock Is a Sweet Idea with Sour Finances Sending Up Red Flags

LMND stock appeals as a potential disruptor, particularly considering it's appeal to the younger generation. But it's not all sweet when it comes to the group's finances and path to profitability.